near-significantp = 0.095
Progression-Free Survival and Workflow Variables: The progression-free survival (PFS) patterns paralleled those observed for OS: median PFS was not reached in patients without pre-biopsy corticosteroid exposure, whereas patients who received steroids had a median PFS of 10.5 months, with a near-significant difference observed in log-rank testing ( p = 0.095).